177 related articles for article (PubMed ID: 11159174)
21. Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice.
Yamada ES; Respondek G; Müssner S; de Andrade A; Höllerhage M; Depienne C; Rastetter A; Tarze A; Friguet B; Salama M; Champy P; Oertel WH; Höglinger GU
Exp Neurol; 2014 Mar; 253():113-25. PubMed ID: 24389273
[TBL] [Abstract][Full Text] [Related]
22. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
23. Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast.
Vanhelmont T; Vandebroek T; De Vos A; Terwel D; Lemaire K; Anandhakumar J; Franssens V; Swinnen E; Van Leuven F; Winderickx J
FEMS Yeast Res; 2010 Dec; 10(8):992-1005. PubMed ID: 20662935
[TBL] [Abstract][Full Text] [Related]
24. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
25. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.
Nacharaju P; Lewis J; Easson C; Yen S; Hackett J; Hutton M; Yen SH
FEBS Lett; 1999 Mar; 447(2-3):195-9. PubMed ID: 10214944
[TBL] [Abstract][Full Text] [Related]
26. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau.
Aoyagi H; Hasegawa M; Tamaoka A
J Biol Chem; 2007 Jul; 282(28):20309-18. PubMed ID: 17526496
[TBL] [Abstract][Full Text] [Related]
27. FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract.
Han D; Paudel HK
Neurochem Int; 2009 Jan; 54(1):14-27. PubMed ID: 18992292
[TBL] [Abstract][Full Text] [Related]
28. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
[TBL] [Abstract][Full Text] [Related]
29. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C
FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306
[TBL] [Abstract][Full Text] [Related]
30. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques.
Ishida C; Kobayashi K; Kitamura T; Ujike H; Iwasa K; Yamada M
Neuropathology; 2015 Feb; 35(1):75-82. PubMed ID: 25377499
[TBL] [Abstract][Full Text] [Related]
31. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
[TBL] [Abstract][Full Text] [Related]
32. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
[TBL] [Abstract][Full Text] [Related]
33. Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau.
Yanagi K; Tanaka T; Kato K; Sadik G; Morihara T; Kudo T; Takeda M
Psychogeriatrics; 2009 Dec; 9(4):157-66. PubMed ID: 20377816
[TBL] [Abstract][Full Text] [Related]
34. Tau pathology in a family with dementia and a P301L mutation in tau.
Mirra SS; Murrell JR; Gearing M; Spillantini MG; Goedert M; Crowther RA; Levey AI; Jones R; Green J; Shoffner JM; Wainer BH; Schmidt ML; Trojanowski JQ; Ghetti B
J Neuropathol Exp Neurol; 1999 Apr; 58(4):335-45. PubMed ID: 10218629
[TBL] [Abstract][Full Text] [Related]
35. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Matsumura N; Yamazaki T; Ihara Y
Am J Pathol; 1999 Jun; 154(6):1649-56. PubMed ID: 10362789
[TBL] [Abstract][Full Text] [Related]
36. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 +3-splice site mutation in the tau gene: clinical and pathological features.
Tolnay M; Grazia Spillantini M; Rizzini C; Eccles D; Lowe J; Ellison D
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):368-78. PubMed ID: 10931371
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation.
Lindquist SG; Holm IE; Schwartz M; Law I; Stokholm J; Batbayli M; Waldemar G; Nielsen JE
Eur J Neurol; 2008 Apr; 15(4):377-85. PubMed ID: 18284428
[TBL] [Abstract][Full Text] [Related]
38. Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity.
Butzlaff M; Hannan SB; Karsten P; Lenz S; Ng J; Voßfeldt H; Prüßing K; Pflanz R; Schulz JB; Rasse T; Voigt A
Hum Mol Genet; 2015 Jul; 24(13):3623-37. PubMed ID: 25794683
[TBL] [Abstract][Full Text] [Related]
39. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells.
Vogelsberg-Ragaglia V; Bruce J; Richter-Landsberg C; Zhang B; Hong M; Trojanowski JQ; Lee VM
Mol Biol Cell; 2000 Dec; 11(12):4093-104. PubMed ID: 11102510
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.
Ikeda M; Shoji M; Kawarai T; Kawarabayashi T; Matsubara E; Murakami T; Sasaki A; Tomidokoro Y; Ikarashi Y; Kuribara H; Ishiguro K; Hasegawa M; Yen SH; Chishti MA; Harigaya Y; Abe K; Okamoto K; St George-Hyslop P; Westaway D
Am J Pathol; 2005 Feb; 166(2):521-31. PubMed ID: 15681835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
